"Our previous work has shown that increased levels of oxidative stress and reduced glutathione are not only present in older people, but also in people with HIV, a viral infection, and in patients with diabetes
Semaglutide's benefits extend beyond appetite reduction and weight loss, with growing interest in its effects on insulin resistance and broader metabolic health
The drugs produced faster weight loss
In comparison, someone tapering off completely might use even smaller, non standard amounts, such as 0.125 mg weekly, which is not part of approved dosing guidelines and would require manual adjustment
The onset of clinical benefit in this secondary analysis therefore precedes substantial weight loss and predates the achievement of target maintenance dosing, although the time-to-benefit estimates carry wider confidence intervals than the primary endpoint